Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | August 16, 2011 | ||||
| Last Updated Date | April 24, 2013 | ||||
| Start Date ICMJE | July 2011 | ||||
| Estimated Primary Completion Date | June 2013 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Perceptions about participation in clinical trials for PTSD or TBI as measured via qualitative interview. [ Time Frame: Qualitative interviews will be conducted during an expected average time frame of 12-24 weeks per study participant based on the specific study recruited from. ] [ Designated as safety issue: No ] Perceptions regarding help-seeking attitudes and mental health beliefs which influence the decision to consent or decline participation in clinical treatment trials for PTSD-TBI will be measured via serial qualitative interview framework. |
||||
| Original Primary Outcome Measures ICMJE |
Perceptions about participation in clinical trials for PTSD or TBI as measured via qualitative interview. [ Time Frame: qualitative interviews will be conducted during an expected average time frame of 12 weeks per study participant ] [ Designated as safety issue: No ] Perceptions regarding help-seeking attitudes and mental health beliefs which influence the decision to consent or decline participation in clinical treatment trials for PTSD-TBI will be measured via serial qualitative interview framework. |
||||
| Change History | Complete list of historical versions of study NCT01419223 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
Feasibility of conducting qualitative interviews with active duty military and veterans who consent or decline participation in a PTSD or TBI clinical trial as measured by study participation. [ Time Frame: End of 21-month study recruitment period ] [ Designated as safety issue: No ] Feasibility will be determined by the number of participants anticipated vs. the number actually enrolled in the current study. |
||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD) | ||||
| Official Title ICMJE | Patient Beliefs and Attitudes That Influence Participation in PTSD-TBI Clinical Trials | ||||
| Brief Summary | This is an exploratory qualitative interview study being conducted with a primary objective of examining perceptions held by active military and veterans regarding help-seeking attitudes and mental health beliefs which influence the decision to consent or decline participation in Post-Traumatic Stress Disorder (PTSD) or Traumatic Brain Injury (TBI) clinical trials. Active duty military and/or veterans aged 18 years and older who consent to participate (N = 50), or have recently declined participation (N = 50), in an INTRuST affiliated outpatient clinical trial for deployment-related PTSD or TBI will be recruited. Participants who consent to participate in an INTRuST clinical trial (Group 1) will be interviewed once at the beginning the of the clinical trial, and again following participation in the trial. Participants who decline participation in an INTRuST affiliated outpatient clinical trial (Group 2) will be interviewed once. For participants in both groups, study participation will initiate within 1 month of referral to study. Total duration of study participation is based on the specific clinical trial that the participant is recruitment from; the longest trial is estimated to be 24 weeks or less. Semi-structured qualitative individual interviews will be conducted to carry out a thematic analysis of the data exploring familial, social and institution-level constructs which may influence the subjective experience of the research treatment process. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Active military and/or veterans ages 18 or over who have recently considered participating in an outpatient clinical trial for PTSD or TBI. |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 100 | ||||
| Estimated Completion Date | June 2013 | ||||
| Estimated Primary Completion Date | June 2013 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01419223 | ||||
| Other Study ID Numbers ICMJE | INTRuST- Beliefs and Attitudes | ||||
| Has Data Monitoring Committee | Yes | ||||
| Responsible Party | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | ||||
| Study Sponsor ICMJE | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | ||||
| Collaborators ICMJE | U.S. Army Medical Research and Materiel Command | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | ||||
| Verification Date | April 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||